henhaobio
Sign in

bioRxivCancer BiologyPreprint

Pan-cancer tumor classification by a holistic tumor microenvironment atlas

Shishang QiniD, Du Xiao, Jinhu Li, Nan JiangiD, Tian Diao, Yufei Bo, Qinhang Gao, Liangtao ZhengiD, Xinnan LingiD, Q. GaoiD, Xiangjie Li, Sen GaoiD, Fei Li Tang, Wen ZhangiD, Chenwei LiiD, Peihong Fang, Linnan ZhuiD, Dongfang WangiD, Zemin ZhangiD

PDFDOI

Abstract

The tumor microenvironment (TME) heterogeneity presents a major bottleneck to effective cancer immunotherapies. We address this by establishing a pan-cancer tumor classification system based on the holistic TME cellular components. First, using single-cell transcriptomes from 1,271 patients across 26 cancer types, we compile a TME cellular atlas, leading to the identification of recurrent cell states and multicellular modules across cancer types. Among these, we highlight a type I interferon (IFN-I)-related multicellular module, including IFIT1+ tumor-associated macrophages, as a critical contributor to immune-activation TMEs. From a holistic perspective, pan-cancer TMEs exhibit trichotomous patterns predominantly driven by T, myeloid, and stromal compartments. Leveraging fine-grained TME cellular composition, we further stratify all tumors into 10 stable groups. These groups display varying responses to immune checkpoint blockade (ICB), and each rationally selected therapeutic strategy specifically perturbs the corresponding expression signature. Our pan-cancer tumor classification scheme reveals the underlying patterns of TME heterogeneity and provides a framework for stratifying patients, guiding treatment selection, and developing novel therapeutic options.

Citations
1

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISBarkley '21Combes '21Nieto '20Qian '20Lapuente-Sa '24Nofech-Moze '23
69% semantic matchCancer Biology
D. Barkley, R. Moncada, M. Pour+14 more·bioRxiv·Dec 20, 2021